Intimation of schedule of Earnings Call to be held on May 22, 2026 at 8:30 AM (IST) on Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2026.
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aurobindo Pharma has announced a scheduled earnings call for May 22, 2026 at 8:30 AM IST to discuss the company's audited financial results for Q4 FY26 and the full year ended March 31, 2026. The call will be conducted via Zoom and pre-registration is required. The earnings presentation will be made available on the company's website after the results are announced. This is a routine regulatory filing under SEBI LODR Regulation 30(2) informing analysts and investors about the upcoming earnings disclosure.
This is a standard scheduling announcement and does not contain any financial results or disclosures. It simply notifies stakeholders about when the company will discuss its Q4 and full-year FY26 performance. No investment signals can be derived from this filing alone.